1 Forgotten Weed Stock Could Make a Mighty Comeback in 2020

Investors dumped the Canopy Growth stock in 2019 because of its very disappointing performance. New catalysts, however, should help the most popular cannabis producer to make a mighty rebound in 2020.

| More on:
New year 2020 celebration. Gold foil balloons

Image source: Getty Images

The marijuana boom was supposed to happen last year. Many were expecting Canopy Growth (TSX:WEED)(NYSE:CGC) to lead the advance. All eyes, including that of Constellation Brands, were on its founder and erstwhile CEO Bruce Linton.

The American alcoholic beverage giant has a $4 billion investment, or 38% stake in the world’s largest publicly traded cannabis company by market value. With mounting losses after the Q2 2019, the Constellation Brands-controlled board has had enough of Linton’s free-spending ways.

Falling out

The board of directors felt a leadership change was in order, and Linton had to go. In spite of his termination in early July 2019, Linton bought WEED shares, saying the change signals the right time to buy.

From $53.52 on July 3, 2019, the price fell by nearly 65% to $18.78 in mid-November. The value of the entire cannabis industry also collapsed.

Canopy Growth was without a permanent CEO throughout the period. Also, it was dealing with supply issues and was having problems selling cannabis products abroad. More seriously, the company was losing money at a rapid pace.

Right man for the job

The good news came on December 9, 2019. As soon as the company announced the hiring of a new CEO, the stock rose to $28.17. Constellation chose a senior executive to take over the helm. It now appears that Canopy Growth is taking the right track in 2020.

Constellations Brand’s CFO David Klein is the chosen one. He’s leaving his post to take the helm at Canopy Growth effective January 14, 2020. Based on the company’s press release, Klein is the right man for the job.

He brings extensive experience from the consumer-packaged-goods (CPG) and the beverage alcohol industry. He has experienced too operating in highly regulated markets in Canada, Europe, Mexico, and the U.S.

With Klein’s strong financial orientation, expect Canopy Growth to depart from Linton’s boldness and do more belt-tightening. Some analysts, however, are uneasy about the appointment. Klein is facing an acid test given that he has zero experience in the cannabis arena.

Right product mix

A significant catalyst for Canopy Growth to stage a major comeback in 2020 is the improving demand trends in the domestic market. Canada’s Cannabis 2.0 is a potential $2.7 billion industry. Consumers can choose from a variety of product mixes in the legal channel, including the popular edibles.

Expect more retail stores to open too. Canopy Growth is opening ten of its Tokyo Smoke dispensaries in the province of Ontario to widen its retail footprint. Another segment in the derivatives where the company would focus on and lead is cannabis-infused beverages.

Right timing

Canopy Growth is hoping the U.S. federal legalization of cannabis would happen this year. The launching of Fire & Free, a line of hemp-derived CBD products, is part of its pre-legalization expansion. If both components in the U.S. progress well, Canopy Growth’s sales should rise significantly.

Right direction

While Canopy Growth is one of the stocks to watch in 2020, don’t expect instant financial miracles. The catalysts for growth are present, beginning with a new man at the helm. Product margins should improve as cash burn declines. You can decide to buy the stock once the red flags go down.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool recommends Constellation Brands.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »